Population based epidemiology and prognosis of mesothelioma in Leeds, UK

Thorax

Volumn 63, Issue 5, 2008, Pages 435-439

  Chapman, A ^a,b   Mulrennan, S ^a   Ladd, B ^a   Muers, M F ^a  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b FRIARAGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CARBOPLATIN; CISPLATIN; MITOMYCIN; NAVELBINE; PEMETREXED; VINBLASTINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOPSY; CANCER INCIDENCE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOPATHOLOGY; ENDOSCOPIC SURGERY; EVIDENCE BASED MEDICINE; FEMALE; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; MEDICAL DOCUMENTATION; MEDICAL RECORD; MONOTHERAPY; PLEURA EFFUSION; PLEURA MESOTHELIOMA; PLEURODESIS; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; SEX DIFFERENCE; THORAX DRAINAGE; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASBESTOS; ENGLAND; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; PLEURAL NEOPLASMS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 43449124508     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2007.081430     Document Type: Article

References (32)

1. Ribak J, Selikoff JJ. Survival of asbestos insulation workers with mesothelioma. Br J Ind Med 1992;49:732-5.
2. Hodgson JT, McElvenny DM, Darnton AJ, et al. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 2005;92:587-93.
3. Yates DH, Corrin B, Stidolph PN, et al. Malignant mesothelioma in south east England: clinicopathological experience of 272 cases. Thorax 1997;52:507-12.
4. Edwards JG, Abrams KR, Leverment JN, et al. Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax 2000;55:731-5.
5. Steele JPC, Klabastsa A. Chemotherapy options and new advances in malignant pleural mesothelioma. Ann Oncol 2005;16:345-51.
6. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-44.
7. Ellis P, Davies AM, Evans WK, et al. The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systemic review and practice guideline. J Thorac Oncol 2006;1:591-601.
8. British Thoracic Society. Statement on malignant mesothelioma in the United Kingdom British Thoracic Society Standards of Care Committee. Thorax 2007;62:ii1-ii19.
9. Wolanski KD, Whitaker D, Shilkin KB, et al. The use of epithelial membrane antigen and silver stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses. Cancer 1998;82:583-90.
10. Whitaker D, Shilkin KB. Diagnosis of pleural malignant mesothelioma in life: a practical approach. Pathology 1984;143:147-75.
11. Robinson BWS, Musk AW, Lake RA. Malignant mesothelioma. Lancet 2005;366:397-408.
12. Clayson H. Palliative care in mesothelioma: What are the needs of patients and their families. Thesis in preparation. The Hospice of St Mary Furness, University of Sheffield.
13. Antunes G, Neville E, Duffy J, et al. BTS guidelines for the management of malignant pleural effusions. Thorax 2003;58(Suppl II):ii29-38.
14. Howel D, Arblaster L, Swinburne L, et al. Routes of asbestos exposure and the development of mesothelioma in an English region. Occup Environ Med 1997;54:403-9.
15. Howel D, Gibbs A, Arblaster L, et al. Mineral fibre analysis and routes of exposure to asbestos in the development of mesothelioma in an English region. Occup Environ Med 1999;56:51-8.
16. Curran D, Sahmoud T, Therasse P, et al. Prognostic factors in patients with pleural mesothelioma: the European Organisation for Research and Treatment of Cancer Experience. J Clin Oncol 1998;16:145-52.
17. Hernden JE, Green MR, Chahinian AP, et al. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukaemia Group B. Chest 1998;113:723- 31.
18. Peto J, Decarli A, Vecchia C. La Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer 1999;79:666-72.
19. Scott B, Mukherjee S, Lake R, et al. Malignant mesothelioma. In: Hanson, ed. Textbook of lung cancer. London: Martin Dunitz, 2000:273-93.
20. Elmes PC, Simpson MJC. The clinical aspects of mesothelioma. Q J Med 1976;179:427-49.
21. Van Ooijen B, Eggermont AMM, Wiggers T. Subcutaneous tumour growth complicating the positioning of the Denver shunt and intrapleural port-a-catti in mesothelioma patients. Eur J Surg Oncol 1992;18:638-40.
22. Lee G, Baumann MH, Maskell NA, et al. Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists. Chest 2003;124:2229-38.
23. Dresler C, Olak J, Herndon J, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005;127:909-15.
24. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 1995;108:754-8.
25. O'Rourke N, Curto GJ, Paul J, et al. A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma. J Eur Soc Ther Radiol Oncol 2007;84:18-22.
26. De Lajartre AY, Tayot J, De Larjartre, et al. Aspects evoltifs des mesotheliomes pleuraux diffuse. Re Fr Mal Resp 1979;7:277-90.
27. Adams VI, Unni KK. Diffuse malignant mesothelioma of the pleura: diagnostic criteria based on an autopsy study. Am J Clin Pathol 1984;82:15-23.
28. Ratzer ER, Pool JI, Melamed MR. Pleural mesotheliomas: clinical experience with 37 patients. AJR Am J Roentgenol 1967;99:863-80.
29. Whitwell F, Rawcliffe RM. Diffuse malignant pleural mesothelioma and asbestos exposure. Thorax 1971;26:6-22.
30. Brenner J, Sordillo PP, Magill GB, et al. Malignant mesothelioma of the pleura: review of 123 patients. Cancer 1982;49:2431-5.
31. Law MR, Hodson ME, Turner-Warwick M. Malignant mesothelioma of the pleura: clinical aspects and symptomatic treatment. Eur J Respir Dis 1984;65:162-8.
32. Ruffie P, Feld R, Minkin S, et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 1989;7:1157-68.